ライフサイエンスコーパス: excess risk

1 ics explained approximately one fifth of the excess risk.

2 t therapy to raise renin might mitigate this excess risk.

3 re modifications to the relative or absolute excess risk.

4 isks were used to quantify cardiac mortality excess risk.

5 ith warfarin, thus showing no benefit and an excess risk.

6 delivery or a low birth weight delivery, to excess risk.

7 ch contributing approximately equal absolute excess risk.

8 renin (>/=1 mug/L per h) had no significant excess risk.

9 sed a random-effects model to derive overall excess risk.

10 medications could partially account for this excess risk.

11 mmon, but seemed to involve similar absolute excess risks.

12 eplacement should be provided to limit these excess risks.

13 e composite endpoint were observed (relative excess risk = 1.50, attributable proportion of histologi

14 ular emissions with all cardiovascular EDVs (excess risk = 1.6%, 95% confidence interval: 0.9, 2.4 fo

15 mong head and neck tumor survivors (absolute excess risks =30 versus 11).

16 erated the highest risk estimate for asthma (excess risk = 4.5%, 95% confidence interval: 1.1, 8.0).

17 3.64; 95% CI, 1.34 to 7.93; P=0.02; absolute excess risk, 6.21 cases per 1 million person-years) and

18 absolute excess risks than females (absolute excess risks =7 versus 3), especially among head and nec

19 2.62; 95% CI, 1.26 to 4.82; P=0.02; absolute excess risk, 8.82 cases per 1 million person-years), wit

20 spitalization rate ratios (RRs) and absolute excess risks (AERs) were calculated.

21 andardized incidence ratios (SIRs), absolute excess risks (AERs), and cumulative incidence of subsequ

22 mortality ratios (SMRs) for CVD and absolute excess risks (AERs; number of excess deaths per 10,000 p

23 We report absolute excess risks (AERs; per 10 000 person-years) and cumulat

24 only 1 of these exposures have little or no excess risk after controlling for conventional risk fact

25 cond study (mid-year 2010), the proportional excess risk among smokers (RR-1) approximately doubled o

26 art failure occurs in older individuals, the excess risk and risk factors for heart failure in indivi

27 Early diagnosis and treatment decrease the excess risk, and strategies for identification of affect

28 Standardized mortality ratios, absolute excess risks, and cumulative risks were calculated.

29 The types of malignancies observed at excess risk are similar to those observed in solid organ

30 od; likewise, the potential reasons for this excess risk are unclear.

31 association and strategies to mitigate this excess risk are warranted.

32 Much of this calculated excess risk arises from exposures to PAHs in early child

33 The excess risk associated with lower CC16 concentrations is

34 ish childhood cancer survivors, the greatest excess risk associated with subsequent primary neoplasms

35 ith nondiabetic patients, there were similar excess risks associated with ITDM/NITDM in patients sele

36 Excess risks attenuated over time and were generally no

37 y, age, or stroke severity, but the absolute excess risk attributable to alteplase was bigger among p

38 embolism; however, it is uncertain when this excess risk begins.

39 This represented an 11% excess risk compared to the reference population, mainly

40 The excess risk conferred by carriage of the combination of

41 The excess risks declined over calendar periods: during the

42 ions in African Americans might reduce their excess risk deserves further study.

43 and cumulative SHS exposures, with relative excess risk due interaction for parental asthma and over

44 3.44-46.91) for their joint effect (relative excess risk due interaction, 9.08 [-0.22 to 43.18]).

45 RR] during drug exposure vs nonexposure) and excess risk due to concomitant drug exposure (relative e

46 tive individuals, respectively, and relative excess risk due to interaction (RERI) 3.34 (95% CI, -1.5

47 Rose and van der Laan criticize the relative excess risk due to interaction (RERI) measure, the use o

48 the highest risk of COWO [RR>/=2.0, relative excess risk due to interaction (RERI) not significant].

49 obesity (BMI >/=30) and calculated relative excess risk due to interaction (RERI) on an additive sca

50 int effects were assessed using the relative excess risk due to interaction (RERI).

51 e interaction was assessed with the relative excess risk due to interaction (RERI).

52 ntified a statistically significant relative excess risk due to interaction (uncorrected P = 4.51 x 1

53 rate lifetime drinking and binging (relative excess risk due to interaction = 0.33, 95% CI: 0.10, 0.5

54 and poor oral health was observed (relative excess risk due to interaction = 1.28, 95% confidence in

55 5% confidence interval: 1.74, 6.01; relative excess risk due to interaction = 2.15, 95% confidence in

56 k due to concomitant drug exposure (relative excess risk due to interaction [RERI]).

57 We estimated the relative excess risk due to interaction and its 95% confidence in

58 There was no evidence of synergism (i.e., excess risk due to interaction) between malaria infectio

59 their effects on food allergy risk (relative excess risk due to interaction, 15.11; 95% CI, 4.19-35.3

60 interactions on both the additive (relative excess risk due to interaction, 5.06; 95% CI, 1.33-11.04

61 Relative excess risk due to interaction, attributable proportion

62 dichotomous exposures, such as the relative excess risk due to interaction, using case-control data

63 ative, and facilitate estimation of relative excess risk due to interaction.

64 ethnicity by calculating the weekly relative excess risk due to interaction.

65 ivity was assessed by estimating the reduced excess risk due to interaction.

66 raction effect, referred to as the "relative excess risk due to interaction." In this article, we rei

67 ross defects, were constructed, and relative excess risks due to interaction were calculated.

68 Relative excess risks due to interaction, attributable proportion

69 Although this excess risk during therapy is likely due to multiple fac

70 analysis was then applied to estimate pooled excess risks (ER).

71 Hospital excess risk estimates range from -1.4% to 2.0% across me

72 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95

73 iovascular events, statistically significant excess risk for ACVD was reported in individuals with pe

74 The excess risk for all-cause dementia observed for individu

75 Our novel observations of an excess risk for AML/MDS following IgG/IgA (but not IgM)

76 rticularly men who have sex with men, are at excess risk for anal cancer, it has been difficult to di

77 while protecting these patients against the excess risk for bleeding.

78 ny of 3 questions: What is the incidence and excess risk for breast cancer in women after chest radia

79 However, the period of excess risk for BVS ended at 3 years, coincident with co

80 Compared with essential hypertension, the excess risk for cardiovascular events and mortality was

81 nsitive to treatment effectiveness, absolute excess risk for CHF, and asymptomatic left ventricular d

82 However, the excess risk for CP among these infants is unknown.

83 th lower degrees of TSB level elevation, the excess risk for CP is minimal.

84 The excess risk for diabetes was practically absent in those

85 calculate adjusted relative risks (aRRs) and excess risk for fever on days 0 to 1, adjusted for age g

86 served significant (p </= 0.01) dose-related excess risk for male breast cancer incidence and mortali

87 T2DM diagnosed at <=40 years had the highest excess risk for most outcomes relative to controls with

88 Excess risk for nonfatal hemorrhagic stroke appeared con

89 d Trade Center Health Registry, there was an excess risk for prostate cancer, thyroid cancer, and mye

90 Interaction tests further indicated that the excess risk for self-harm/suicide related to bariatric s

91 d standardised incidence ratios and absolute excess risk for subsequent neoplasms with age-specific,

92 e number and percentage of participants with excess risk for symptoms post-MMR3.

93 n fertilizer use and water arsenic (relative excess risk for the interaction = 0.06, 95% confidence i

94 east cancer, increase with age; however, the excess risk for these conditions that can be attributed

95 Determining those at excess risk for transplant is critical to these imperati

96 h standardized mortality ratios and absolute excess risks for ischemic heart disease, valvular heart

97 The excess risks for lung and urinary tract cancers were hig

98 for female breast cancer, although absolute excess risks for males are much less than for females.

99 for CVD and non-CVD mortality were <1, with excess risks for other CVD outcomes substantially attenu

100 The relative excess risks for the interactions between smoking status

101 Excess risk from concomitant use of nsNSAIDs with select

102 eased risk of dying from CRC, although these excess risks have declined substantially over time.

103 hase (mean follow-up, 22 years) did not have excess risk (HR, 1.02; 95% CI, 0.72-1.44) but those with

104 The excess risk in blacks compared with whites (age-adjusted

105 one system (RAAS) inhibition does not confer excess risk in heart failure patients with reduced eject

106 risk factors for AIDS mortality, whereas the excess risk in MSM was unchanged.

107 There was no indication of an excess risk in persons younger than 50 years.

108 st to suggest a potential modest synergistic excess risk in those with comorbid TBI/PTSD.

109 tal morbidity, there was weak evidence of an excess risk in women taking tricyclic antidepressants, a

110 Recent studies have reported excess risk in workers who are occupationally exposed to

111 population, varied greatly, from substantial excess risks in large patient groups to lower risks of d

112 This association was accentuated (5-fold excess risk) in individuals with previous severe immunod

113 artan treatment in HFpEF was associated with excess risk, in contrast to WRF occurring with RAAS bloc

114 lence of periodontitis, even low to moderate excess risk is important from a public health perspectiv

115 eases with increasing BMI and the associated excess risk is much greater after surgery than without s

116 sociation of ADEM with Tdap vaccine, but the excess risk is not likely to be more than 1.16 cases of

117 ch cardiac rhythm subset, but persistence of excess risk is observed for each type of AF.

118 perative characteristics further enhance the excess risk is scarce.

119 This excess risk is similar regardless of ejection fraction b

120 red with that in the general population, but excess risk is substantially lower after transient ischa

121 jointly accounted for approximately half the excess risk linked with maternal psychiatric inpatient h

122 However, the percentage of excess risk mediated (PERM) by these proximate causes of

123 We calculated the percentage of excess risk mediated by risk factors to assess the exten

124 lic abnormalities did not confer substantial excess risk, not even for severe or long-lasting obesity

125 exposure of the heart to radiation to avoid excess risk of ACEs after radiotherapy for BC.

126 Conclusion The excess risk of acute myeloid leukemia and/or myelodyspla

127 tertile was associated with an even greater excess risk of advanced fibrosis than advanced inflammat

128 It remains disputed whether women are at excess risk of adverse outcomes versus men after non-ST-

129 and hospital admission during follow-up, the excess risk of AIDS-related death decreased for heterose

130 erial administration was not associated with excess risk of AKI acute kidney injury , dialysis, or de

131 Ethnic minorities were also at excess risk of all psychotic disorders (1.75 [1.53-2.00]

132 In SEER 9, there was a significant excess risk of all types of second cancers combined (SIR

133 The excess risk of all-cause and cardiopulmonary mortality f

134 As a primary contributor to the excess risk of all-cause and cardiovascular death in dia

135 h type 1 diabetes have a roughly 40% greater excess risk of all-cause mortality, and twice the excess

136 Recently, an excess risk of AML/MDS was found among 5652 patients wit

137 compared with the general population had an excess risk of anal cancer, with SIRs of 109.8 (95% CI,

138 The excess risk of antibiotic use and hospital-treated infec

139 ssel and cardioembolic subtypes, they had no excess risk of asymptomatic carotid disease (adjusted OR

140 The excess risk of atrial fibrillation in individuals with t

141 Among individuals with normoalbuminuria, no excess risk of atrial fibrillation was noted in men with

142 rofound B-cell deficiency associated with an excess risk of bacterial infection and higher mortality.

143 Absolute excess risk of biliary tract disease associated with ADP

144 ducation received also seemed to explain the excess risk of black race in the discrepant group that r

145 was heterogeneity with one study showing an excess risk of campylobacteriosis.

146 pients should balance the harms, such as the excess risk of cancer against the survival gains and qua

147 risk factors, we converted absorbed doses to excess risk of cancer incidence and used them to directl

148 ll, survivors have a clear radiation-related excess risk of cancer, and people exposed as children ha

149 s has been shown to unequivocally reduce the excess risk of cardiovascular complications.

150 Cancer survivors might have an excess risk of cardiovascular disease (CVD) resulting fr

151 ents with chronic kidney disease, experience excess risk of cardiovascular disease and elevated total

152 Excess risk of cardiovascular disease occurs in effectiv

153 associated with heightened inflammation and excess risk of cardiovascular disease, cancer and other

154 Diabetes confers a two times excess risk of cardiovascular disease, yet predicting in

155 th systemic lupus erythematosus (SLE) are at excess risk of cardiovascular events (CVEs).

156 HIV-infected adults have excess risk of cardiovascular, liver, kidney, bone, and

157 The excess risk of cerebral infarction among CNS tumor survi

158 approximately 0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% c

159 ational studies suggest an approximately 40% excess risk of CHD in employees working long hours.

160 Excess risk of concomitant use of nsNSAIDs with anticoag

161 Whether smoking confers the same excess risk of coronary heart disease for women as it do

162 hildhood immunisation in Africa outweigh the excess risk of COVID-19 deaths associated with vaccinati

163 An excess risk of CVD occurs early in the RA disease course

164 was significantly associated with increased excess risk of death (RER 1.48, 95% CI 1.31-1.68, p-valu

165 y-based observational study to determine the excess risk of death according to the level of glycemic

166 th stages I to IIA disease had no noteworthy excess risk of death after they reached EFS24, whereas r

167 hing by insurance explained one third of the excess risk of death among nonelderly black versus white

168 Long-term trends in excess risk of death and cardiovascular outcomes have no

169 d optimal levels for risk factors related to excess risk of death and cardiovascular outcomes in type

170 The excess risk of death associated with a high BMI, however

171 HR: 0.96; 95% CI: 0.58 to 1.53), whereas the excess risk of death associated with HG aortic stenosis

172 mer smokers have about only a quarter of the excess risk of death compared to current smokers.

173 Our study found an excess risk of death due to both liver-specific and non-

174 The excess risk of death from any cause and of death from ca

175 The excess risk of death from ischemic, but not hemorrhagic,

176 stics matching accounted for the 54% and 27% excess risk of death in black patients, respectively.

177 rs combined accounted for 76.3% of the total excess risk of death in black patients; insurance accoun

178 The excess risk of death in black versus white men diagnosed

179 In those age >/= 65 years, the excess risk of death in blacks versus whites was nonsign

180 pared to matched controls, and over half the excess risk of death was due to seemingly unrelated co-m

181 Atrial fibrillation carries an excess risk of death, which is the highest for AF develo

182 rated that statin therapy is associated with excess risk of developing diabetes mellitus.

183 abetes during 2006 and 2007, we measured the excess risk of developing diabetes triggered by undernou

184 ) up to the age of 4 years are at a 150-fold excess risk of developing myeloid leukemia (ML-DS).

185 tients with metabolic syndrome were at a 21% excess risk of developing subclinical hypothyroidism (ad

186 Survivors of childhood cancer are at excess risk of developing subsequent primary neoplasms b

187 rum potassium appeared to explain 18% of the excess risk of diabetes in African Americans, which is c

188 that low serum potassium contributes to the excess risk of diabetes in African Americans.

189 We found a massive excess risk of diabetes in people born during the times

190 eded statin therapy may be withheld to avoid excess risk of diabetes while representing the strongest

191 In contrast, a modest excess risk of disability was observed in African Caribb

192 An excess risk of DLBCL and FL was found in Q fever patient

193 The excess risk of each cause of death in the 5 years subseq

194 aortic aneurysm (rAAA) were associated with excess risk of early mortality in women.

195 a BMI of 22.6 to 25.0, whereas there was no excess risk of either death from any cause or cause-spec

196 ng kidney donation may be associated with an excess risk of end-stage kidney disease and death.

197 s risk of all-cause mortality, and twice the excess risk of fatal and nonfatal vascular events, compa

198 The excess risk of fever after TIV and PCV13 was 20 and 23 p

199 ior exposure in utero was associated with an excess risk of food sensitization at age 4 years (OR 1.4

200 There was an excess risk of genitourinary tract cancers among recipie

201 We aimed to determine the excess risk of heart failure in individuals with type 1

202 This excess risk of hemorrhagic stroke is particularly high i

203 The excess risk of hepatoblastoma was associated with low bi

204 diographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.

205 The excess risk of HF associated with CKD was particularly l

206 The apparent excess risk of HS in patients with previous IE was expla

207 mediate variables that explained the highest excess risk of IHD from genetically determined obesity w

208 ure with 7%, and remnant cholesterol with 7% excess risk of IHD.

209 The excess risk of incident heart failure in black women is

210 a than are their non-pregnant peers, and the excess risk of infection varies with gravidity.

211 Current international migrants had no excess risk of injury in the past 12 months compared to

212 The relative excess risk of interaction was -0.34 (95% CI: -0.60, -0.

213 r baseline stroke severity, but the absolute excess risk of intracerebral haemorrhage increased with

214 e benefits of RV5 and RV1 outweigh the small excess risk of intussusception.

215 dent colorectal cancer, but we did see a 19% excess risk of invasive breast cancer among those with A

216 acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events.

217 Among 23,118,656 singleton live births, the excess risk of IUGR among Black women, Hispanic women, a

218 We aimed to assess the excess risk of leukaemia and brain tumours after CT scan

219 Coinfection with S. mekongi resulted in excess risk of liver fibrosis and left liver lobe enlarg

220 imate the age-specific risk of infection and excess risk of LTBI from household and community exposur

221 Estimates of the relative excess risk of lung cancer mortality due to interaction,

222 robiota profile was associated with a 2-fold excess risk of metabolic syndrome, driven by increase in

223 with DM between 1998 and 2010; however, the excess risk of MI incidence remains 3 to 4x greater in p

224 Despite the excess risk of mortality in young women (</=55 years of

225 It has been hypothesized that the observed excess risk of multiple myeloma (MM) among obese persons

226 herbicides, fungicides) are associated with excess risk of multiple myeloma and its precursor state,

227 The excess risk of myopathy was only two per 10,000 patients

228 An excess risk of nonmelanoma skin cancer was observed subs

229 alkylating chemotherapy carries little to no excess risk of POF.

230 However, the magnitude of excess risk of premature death and incident complication

231 Excess risk of psychiatric illness associated with child

232 s explained 65.3% (95% CI 37.9-92.8%) of the excess risk of SCD in blacks in comparison with whites.

233 des overall population benefit, there was an excess risk of severe dengue in seronegative vaccinees.

234 The percentage of excess risk of SGA birth that was mediated was 7% in Bla

235 height with poor GWG was associated with an excess risk of SGA birth, while high GWG combined with e

236 The adjusted excess risk of SIEs in nonbreastfed infants was large be

237 The excess risk of small airway disease in female mice after

238 x and oropharynx cancers carried the highest excess risk of SPM.

239 t trimester of pregnancy would mark women at excess risk of spontaneous preterm birth (sPTB) and exam

240 The excess risk of stroke associated with diabetes is signif

241 Whether and to what extent the excess risk of stroke conferred by diabetes differs betw

242 erapy in both study groups and estimated the excess risk of stroke death associated with nonadherence

243 The excess risk of stroke remained unchanged in analyses tha

244 ence ratios were calculated to determine the excess risk of subsequent breast cancer compared with th

245 The relative excess risk of T2DM was 4.78 for individuals who smoked

246 These results indicate that any excess risk of these cancers, even from relatively high

247 in African Americans may contribute to their excess risk of type 2 diabetes relative to whites.

248 ists, or anticoagulants produces significant excess risk of UGIB.

249 disorders seemed to account for some of the excess risk of unnatural death among people with dual-ha

250 However, because the excess risk of venous thromboembolic events (VTEs) with

251 models, liraglutide was not associated with excess risk of WRF compared with placebo (odds ratio, 1.

252 No excess risks of bleeding or other serious adverse events

253 Significant excess risks of both outcomes were observed in obese wom

254 Specifically, we observed significant excess risks of cancers of the endometrium (n = 11; obse

255 The 10-year absolute excess risks of CD and UC were 0.9 (95% CI 0.7-1.1) and

256 The excess risks of death from any cause and cardiovascular

257 The excess risks of death from any cause and death from card

258 ne third of all deaths; the largest absolute excess risks of death were from renal disease (rate rati

259 There was no evidence of excess risks of hepatitis (21 [0.5%] vs 18 [0.4%]), gall

260 No excess risks of hypercalcemia or other adverse events we

261 cting results(11-13), and concerns about the excess risks of ICH associated with lowering LDL-C(14,15

262 .29-3.13) were both associated with moderate excess risks of later ASDs, whereas the HR for later ASD

263 There were significant excess risks of major coronary event (2.44, 95% CI 2.18-

264 The excess risks of mental, physical, and social health outc

265 ight indicate an association with HPV, while excess risks of other cancers could point to differences

266 No reported excess risks of pneumonia (5% in the placebo group, 6% i

267 gh patients with cardiovascular disease face excess risks of severe illness with coronavirus disease-

268 We calculated a risk difference (excess risk) of TM and ADEM for each vaccine.

269 sure range, with an indication of a possible excess risk only at the highest levels.

270 ametric survival models to estimate absolute excess risks over time.

271 h among people with dual-harm histories, but excess risk, particularly of accidental death, persisted

272 a visits showed associations (for 2-day lag, excess risk per 10 mug/m(3) = 3.3%, 95% confidence inter

273 d hospitalization ratios (SHRs) and absolute excess risks per 10 000 person-years.

274 -MOST intracerebral haemorrhage the absolute excess risk ranged from 1.5% (0.8-2.6%) for strokes with

275 For head and neck tumor survivors, this excess risk remains high across all ages.

276 extent (12.8) and also produced the greatest excess risk (RERI, 5.5).

277 aimed to establish the extent to which this excess risk should be attributed to harmful effects of t

278 US hospitals receive financial penalties for excess risk-standardized 30-day readmissions and mortali

279 peratures, increasing risk temperatures, and excess risk temperatures were statistically identified t

280 Males had significantly higher absolute excess risks than females (absolute excess risks =7 vers

281 Corresponding observational excess risks using conventional body mass index were 21%

282 Excess risk varied by cancer type (greatest for lung), c

283 However, the excess risk varied markedly by type of birth defect.

284 The amount of the adjusted excess risk varies by type of cardiovascular outcome and

285 [CI], 1.2-471.6; P = .04), and the estimated excess risk was 0.385 (95% CI, -.04 to 1.16) cases per m

286 The maximum absolute excess risk was at attained ages 50 to 59 years.

287 This excess risk was evident for external and nonexternal cau

288 This excess risk was much smaller than that observed during t

289 The excess risk was not explained by age and comorbidities.

290 for VTE the first year after discharge, the excess risk was not greater in patients with RA than in

291 A pattern of excess risk was noted in UNHCR-managed camp data where t

292 While no excess risk was observed during the first trimester, the

293 No excess risk was observed for breast cancer in premenopau

294 This excess risk was observed in individuals with a history o

295 s adjusted for sociodemographic factors; the excess risk was unchanged after adjustment for cognitive

296 Absolute excess risks were calculated by subtracting cause-specif

297 However, absolute excess risks were generally greater with increasing age.

298 Standardized mortality ratios and absolute excess risks were used to quantify cardiac mortality exc

299 D was present versus 2.17-fold and 2.80-fold excess risk when PTSD was absent.

300 The pattern of excess risk with a maximum BMI above normal weight was m